| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.798 | 4.006 | 2.872 | 0 | 0 | 0 | 0 | - | - | - |
| Total Income - EUR | 3.798 | 4.006 | 2.872 | 0 | 0 | 0 | 0 | - | - | - |
| Total Expenses - EUR | 5.614 | 7.830 | 7.493 | 0 | 0 | 0 | 0 | - | - | - |
| Gross Profit/Loss - EUR | -1.816 | -3.824 | -4.621 | 0 | 0 | 0 | 0 | - | - | - |
| Net Profit/Loss - EUR | -1.930 | -3.904 | -4.658 | 0 | 0 | 0 | 0 | - | - | - |
| Employees | 2 | 2 | 2 | 0 | 0 | 0 | 0 | - | - | - |
Check the financial reports for the company - True Blood S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Current Assets | 1.672 | 835 | 912 | 895 | 878 | 861 | 842 | - | - | - |
| Inventories | 1.046 | 229 | 98 | 96 | 94 | 93 | 91 | - | - | - |
| Receivables | 582 | 560 | 812 | 797 | 782 | 767 | 750 | - | - | - |
| Cash | 44 | 46 | 2 | 2 | 2 | 2 | 2 | - | - | - |
| Shareholders Funds | -5.045 | -8.897 | -13.404 | -13.158 | -12.903 | -12.659 | -12.378 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 6.716 | 9.733 | 14.316 | 14.054 | 13.781 | 13.520 | 13.220 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - True Blood S.r.l.